Clinical Trials on Mammary Gland Hyperplasia

Total 37393 results

Mansoura University

Completed

HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH

Prostatic Hyperplasia

Egypt
GlaxoSmithKline

Completed

A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use

Prostatic Hyperplasia
Xiangfu Zhou

Unknown

The Influence of Benign Prostatic Hyperplasia on Bladder Function

Prostatic Hyperplasia

China
Mansoura University

Unknown

Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the Prostate

Prostatic Hyperplasia

Egypt
Korean Gynecologic Oncology Group

Unknown

Comparison of Dilatation & Curettage and Endometrial Aspiration Biopsy Accuracy in Patients Treated With Progestin for Endometrial Hyperplasia: A Korean Gynecologic Oncology Group Study

Endometrial Hyperplasia

Korea, Republic of
Boehringer Ingelheim

Completed

Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Drug Use Investigation for AVOLVE(BPH)

Prostatic Hyperplasia
The Catholic University of Korea

Unknown

Functional Changes of Urogenital System After Holmium Laser Prostatectomy

Prostatic Hyperplasia

Korea, Republic of
Milton S. Hershey Medical Center
Center for Research on Women and Newborn Health

Withdrawn

Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)

Endometrial Hyperplasia
Sanofi

Completed

ALF-ONE : ALFuzosin ONcE Daily

Prostatic Hyperplasia
Sanofi

Completed

Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin (SAMBA-Thailand)

Prostatic Hyperplasia

Thailand
Handok Inc.

Completed

Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study

Prostatic Hyperplasia

Korea, Republic of
Sanofi

Terminated

ALF-STONE: Alfuzosin in Uretheric Stones

Prostatic Hyperplasia

Portugal
GlaxoSmithKline

Completed

Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)

Prostatic Hyperplasia | Prostatitis

Italy
Queen's University

Completed

Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia

BPH

Canada
University Hospital, Bordeaux

Recruiting

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction (PARTURP)

Benign Prostatic Hyperplasia

France
Changhai Hospital

Unknown

Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship

Prostatic Neoplasms | Benign Prostatic Hyperplasia | Digital Rectal Examination

China
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)

Erectile Dysfunction | Benign Prostate Hyperplasia

China
GlaxoSmithKline

Completed

Economic Analyses of the REDUCE Trial

Cancer | Benign Prostatic Hyperplasia | Neoplasms, Prostate
Nymox Corporation

Completed

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)

Benign Prostatic Hyperplasia | BPH | LUTS | Lower Urinary Tract Symptoms (LUTS)

United States
Eli Lilly and Company

Completed

A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia (COMORBID©)

Benign Prostatic Hyperplasia | Erectile Dysfunction

United States, France, Italy, Greece, Mexico, Portugal, Canada, Germany, Russian Federation
Dong-A Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Korea, Republic of
Boston Scientific Corporation

Completed

Rezum I Pilot Study for Benign Prostatic Hyperplasia (Rezum Pilot)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | Rezum

Dominican Republic, Czechia, Sweden
Boston Scientific Corporation

Completed

Rezum FIM Optimization Study (Rezum FIM)

Benign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | Rezum

Dominican Republic
Emory University

Completed

Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer

Breast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of Breast | Cancer of the Breast | Human Mammary Carcinoma

United States
Krankenhaus Barmherzige Schwestern Linz

Completed

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Endometrial Cancer | Atypical Hyperplasia

Austria
Istanbul University

Completed

Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia

Acute Hyponatremia

Turkey
Hanmi Pharmaceutical Company Limited

Completed

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin

Prostatic Hyperplasia

Brazil
GlaxoSmithKline

Completed

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (ARI114694)

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

Prostatic Hyperplasia
Universität des Saarlandes

Completed

Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia

Benign Prostatic Hyperplasia | Primary Prostate Urothelial Cancer

Germany
GlaxoSmithKline

Completed

Korean Practice Patterns for Screening PCA(Prostate Cancer) (RESPECT)

Benign Prostatic Hyperplasia | Prostate Cancer | Neoplasms, Prostate

Korea, Republic of
Dr Vincent Misrai
Boston Scientific Corporation; Iqvia Pty Ltd

Recruiting

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP)

Benign Prostatic Hyperplasia | Anticoagulant Adverse Reaction

France
University of California, San Diego

Completed

Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Prostatic Hyperplasia, Benign | Enlarged Prostate With Lower Urinary Tract Symptoms

United States
Can-Am HIFU Inc.

Recruiting

Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).

Urologic Diseases

Canada
GlaxoSmithKline

Completed

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (ARI115707)

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database

Prostatic Hyperplasia
University Hospital Padova

Recruiting

Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn (WHYSKI)

Hypertension | Essential Hypertension | Hyperaldosteronism | Aldosteronism | Conn Adenoma | Aldosterone Disorder | Aldosterone-producing Adenoma | Bilateral Adrenal Hyperplasia

Italy
Kasr El Aini Hospital

Completed

SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes

Diabetes Mellitus | Prostatic Hyperplasia

Egypt
West China Second University Hospital

Recruiting

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

Atypical Endometrial Hyperplasia | Endometrial Cancer

China
Hopital Foch

Completed

Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level (STERPROSER)

Urinary Bladder Neoplasms | Prostate Hyperplasia

France
ProstaCare Pty Ltd

Not yet recruiting

Neuflo System for the Treatment of BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia
ProArc Medical

Recruiting

Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH (Omega)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Georgia
Société Internationale d'Urologie

Recruiting

BPH Global Registry

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada, Italy, United Kingdom, Cyprus, United States, Chile

Clinical Trials on Mammary Gland Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations